Apoptosis inhibitor abolished and restored rTsSPc-disrupted Caco-2 monolayer barrier integrity. حسب Qi Qi Lu (17721401)

الموضوعات:

Specific primer sequences of human gut epithelial TJs and apoptosis-related genes for qPCR. حسب Qi Qi Lu (17721401)

الموضوعات:

rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells. حسب Qi Qi Lu (17721401)

الموضوعات:

Raw data of Figs 1–6 in this study. حسب Qi Qi Lu (17721401)

الموضوعات:

Inhibition of PGAM5 and apoptosis prevented <i>T. spiralis</i> larval invasion of Caco-2 monolayer. حسب Qi Qi Lu (17721401)

الموضوعات:

Test equipment. حسب Haotian Guo (6620120)

Test Schedule. حسب Haotian Guo (6620120)

RipE1 undergoes phosphorylation in <i>N. benthamiana</i>, which contributes to protein stability. حسب Wenjia Yu (9422059)

NbUCH positive regulates RipE1 accumulation in <i>N. benthamiana.</i> حسب Wenjia Yu (9422059)

RipE1 phosphorylation and NbUCH-mediated deubiquitination are independent mechanisms leading to RipE1 stability. حسب Wenjia Yu (9422059)

RipE1 interacts with NbUCH12 and NbUCH15. حسب Wenjia Yu (9422059)

NbUCH15 promotes RipE1 stability by deubiquitination. حسب Wenjia Yu (9422059)

Silencing <i>NbUCHs</i> triggers SGT1-dependent immunity in <i>N. benthamiana.</i> حسب Wenjia Yu (9422059)

Parallel trend test. حسب Wei Wang (17594)

"…After the policy was implemented (with a positive relative time), the regression coefficient increased significantly and reached a peak at a relative time of 3, and then decreased slightly. …"

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. حسب Omid Mehrpour (9385929)

الموضوعات:

Mean and standard error of pupil diameter in the dim states. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Averaged pupillary responses in bright and dark conditions. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Mean and standard error of sensory properties. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Rate of missing trials. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Medication Use Status of ASD Participants (n = 17). حسب Tomoe Hayakawa (20978784)

الموضوعات: